is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
What you need to know if you are contemplating entering the promising and yet ever-crowded hemp product marketplace
While the discovery of novel ingredients and emerging scientific research often converge to yield exciting new functional product territories, little compares to what is happening right now in the world of Hemp in general and cannabidiol (CBD) in particular.
CBD isolate became an FDA approved drug for the treatment of epilepsy in June of 2018. Since that time, consumer, retailer, manufacturer, and investor interest — both in the particular CBD compound and the much broader range of hemp-derived cannabinoids, terpenes, and flavonoids — has dramatically expanded as new product forms and formulations have proliferated. And yet this bourgeoning new product segment is unfolding in the midst of a state-by-state regulatory patchwork; and FDA oversight and “ enforcement discretion” has been limited to warning letters issued only to those companies making egregious disease and health claims.
In this module of the NBJ Summit, we will separate fact from fiction and hear from legal experts, investment professionals, and entrepreneurs on the potential risks and rewards in entering this dynamic market segment.
Registration for the NCN Hemp Investor Forum is $595
If you would like to register for both the NCN Hemp Investor Forum and NBJ Summit the combined price is $3,245 (a $750 savings with promo code NCN750). Learn more about NBJ Summit.
NCN Cornerstone Investors and Sponsors – for your complimentary registration please call or email our Client Services Representative, Jill Ramar, at Jill.firstname.lastname@example.org or 303.998.9080
2:00 – 2:10PM Opening Remarks
2:10 – 2:45PM Executive Summary: State of the Hemp Industry
An immense new market segment is taking form in hemp derived products, with CBD as the first big expression of the potential for non-psychoactive components. This session will focus on the emerging (but far from complete) science and how to safely and responsibly participate in this new dynamic market. The session will include identifying and mitigating risk factors and particular due diligence considerations in evaluating suppliers and/or investment opportunities in hemp and CBD.
2:45 – 3:00 PM NBJ Numbers & Market Overview
Predictions for the hemp CBD sales have been marked by wild variations of “up,” but NBJ brings its established reputation for market projection to this session with trend data not just on sales of CBD, but also where consumers are finding it, what they know (and don’t know) about it and what money coming into the space could mean.
3:00 – 3:20 PM State of the Regulatory Landscape for CEOs and Investors
Are you considering investing in a company that sells products with hemp based ingredients? What are the strategic and compliance issues that you need to consider? What diligence do you need to conduct to help ensure legal compliance? This session examines the strategic and legal issues surrounding these investments with tips to help manage risk.
3:20 – 3:40 PM State of the Science for Investors
For both brands and consumers, confusion too often outpaces science on hemp CBD, but this session reviews the latest research on hemp extracts, CBD, related phytocannabinoids and other important chemistries. This science update includes vital information on how product development should be influenced by dose, dosage form, specific health conditions, pharmacokinetics and safety. Investors will learn the most important points sourcing, quality and testing concerns.
3:40 – 4:00 PM In’s and Out’s of Investing in Hemp: Investor Checklist
Enthuisasm bordering on evangelism has long been the face the hemp CBD entrepreneur, but smart investors approach the space with eyes open and wallets tight. This session highlights the “must haves” and “red flags” to look for when evaluating a company.
4:00 – 4:20 PM Investee & Investor: Funding Story
This Q&A session addresses specific investor considerations in a still-uncertain regulatory environment with quality and product integrity standards still being defined. Both the investor and the entrepreneur will address what they were looking for in a funding partnership, and what they have encountered in this emerging marketplace.
The investment picture for the CBD market is not complete without sharing the view from inside the companies that are putting products on shelves. Similar to a pitch slam, but without the direct plea for funding, the Company Highlights segment will feature brands explaining both their product propsition and the challenges they face in a complicated market. To bring this crucial view into a tighter focus, each of the three companies will discuss a different challenge: supply chain, distribution and differentiation.
4:20 - 4:35 PM Opening Remarks
4:35 - 4:44 PM Supply Chain Company Highlight
Lumen will talk about how they are navigating a supply chain that is still being built. With a rapidly growing but not well-supervised network of farmers and suppliers, brands face challenges ensuring their ingredients are both responsibly grown and optimally processed or extracted. With both consumer sophistication and expectations rising every day, brands will need to work confidence into their offerings. Hear from one company how solidifying their supply chain relationships is cementing their product promise.
4:44 - 4:50 PM Hemp Forum Expert Panelists Q&A with Lumen
4:50 - 4:59 PM Distribution Strategy Company Highlight: Weller Snacks
Though the situation is rapidly evolving, distribution in the CBD market has been a remarkably haphazard affair. CBD is sold everywhere from book stores to bike shops with brands often working deals store by store, but with big chains like CVS and Vitamin Shoppe getting into the game, CBD finished product companies will be competing for bigger contracts with bigger implications for long-term growth and brand recognition. The brand in this segment will discuss how they plan to compete in the distribution ecosystem as the door opens to a larger playing field.
4:59 - 5:05 PM Hemp Forum Expert Panelists Q&A with Weller Snacks
5:05 - 5:14 PM Differentiation Company Highlight: Sagely Naturals
Because the market is getting bigger means it is getting more crowded. That tasks brands to establish a differentiation story to rise above the churn, both with consumers and probably more importantly with the big chains that may ultimately declare winners and also-rans in the space. Whether it's organic certification, proprietary formulation or a strong traceability story, brands will need to find and then sharpen that edge over the competition. This brand will explain how they intend to use differentiation to make a play for the mass market.
5:14 - 5:20 PM Hemp Forum Expert Panelists Q&A with Sagely Naturals
5:20 - 5:30 PM Closing Remarks
Hemp is a promising emerging segment - but not without regulatory and market risk
Very high growth area - but one where facts and fiction freely interact
Risk assessment - a set of additional considerations that are unique to this market
Supply chain weakness - vulnerabilities to keep in mind from growing to formulation
A conservative approach - with the realization that the time to act is now
Clarity on regulation - DSHEA, FDA, USDA
To assemble highly informed professionals from the legal and investment sphere as well as entrepreneurs and supply chain experts to help inform responsible decision-making in the fast-moving hemp segment.
100 Terranea Way
Rancho Palos Verdes, CA, 90275
We are happy to announce that onPeak will be the official housing vendor for the NCN Hemp Investor Forum.
No other vendor has access to our exclusive event room block and lowest guaranteed rates. Access to the official housing block is only available through your confirmed registration. Discounted rates end July 12.